Logo image of ASMB

ASSEMBLY BIOSCIENCES INC (ASMB) Stock Overview

NASDAQ:ASMB - US0453962070 - Common Stock

25.5 USD
-0.39 (-1.51%)
Last: 8/28/2025, 4:30:00 PM

ASMB Key Statistics, Chart & Performance

Key Statistics
52 Week High27.17
52 Week Low7.75
Market Cap338.13M
Shares13.26M
Float7.97M
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)-5.58
PEN/A
Fwd PEN/A
Earnings (Next)11-05 2025-11-05
IPO12-17 2010-12-17
Sector
GICS SectorHealth Care
GICS IndustryBiotechnology
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryBiotechnology


ASMB short term performance overview.The bars show the price performance of ASMB in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 20 40 60 80

ASMB long term performance overview.The bars show the price performance of ASMB in the last 1, 2 and 3 years. 1 year 2 years 3 years 20 40 60 80 100

The current stock price of ASMB is 25.5 USD. In the past month the price increased by 42.26%. In the past year, price increased by 56.83%.

ASSEMBLY BIOSCIENCES INC / ASMB Daily stock chart

ASMB Competitors/Peers

The largest stocks on the US markets in the "Biotechnology" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
ABBV ABBVIE INC 19.63 367.30B
AMGN AMGEN INC 13.1 153.76B
GILD GILEAD SCIENCES INC 14.54 139.67B
VRTX VERTEX PHARMACEUTICALS INC 23.14 100.52B
REGN REGENERON PHARMACEUTICALS 12.7 61.43B
ALNY ALNYLAM PHARMACEUTICALS INC N/A 59.29B
ARGX ARGENX SE - ADR 75.95 43.09B
ONC BEONE MEDICINES LTD-ADR 6.02 35.42B
INSM INSMED INC N/A 28.53B
BNTX BIONTECH SE-ADR N/A 24.50B
NTRA NATERA INC N/A 23.04B
BIIB BIOGEN INC 8.29 19.45B

About ASMB

Company Profile

ASMB logo image Assembly Biosciences, Inc. is a biotechnology company, which engages in the development of products for infectious diseases, such as chronic hepatitis B virus and illnesses associated with a dysbiotic microbiome. The company is headquartered in South San Francisco, California and currently employs 73 full-time employees. The company went IPO on 2010-12-17. The Company’s pipeline includes two helicase-primase inhibitors (HPI) targeting recurrent genital herpes, an orally bioavailable hepatitis delta virus (HDV) entry inhibitor, a clinical-stage capsid assembly modulator (CAM) designed to disrupt the replication cycle of hepatitis B virus (HBV) at several key points with the aim of achieving finite treatment and functional cures and research programs focused on the discovery of therapeutics to treat devastating viral diseases, including a non-nucleoside polymerase inhibitor (NNPI) targeting transplant-related herpesviruses and a small molecule interferon-α (IFN-α) receptor (IFNAR) agonist targeting HBV and HDV. HPIs are antiviral agents in development for HSV-1 and HSV-2, with a clinically validated mechanism of action. Its HBV, HSV-1, and HSV-2 programs include ABI-6250, ABI-5366, and ABI-1179.

Company Info

ASSEMBLY BIOSCIENCES INC

Two Tower Place, 7Th Floor

South San Francisco CALIFORNIA 94080 US

CEO: John G. McHutchison

Employees: 73

ASMB Company Website

ASMB Investor Relations

Phone: 18334094583

ASSEMBLY BIOSCIENCES INC / ASMB FAQ

What is the stock price of ASSEMBLY BIOSCIENCES INC today?

The current stock price of ASMB is 25.5 USD. The price decreased by -1.51% in the last trading session.


What is the ticker symbol for ASSEMBLY BIOSCIENCES INC stock?

The exchange symbol of ASSEMBLY BIOSCIENCES INC is ASMB and it is listed on the Nasdaq exchange.


On which exchange is ASMB stock listed?

ASMB stock is listed on the Nasdaq exchange.


What is the price forecast or stock price prediction for ASSEMBLY BIOSCIENCES INC stock?

9 analysts have analysed ASMB and the average price target is 36.98 USD. This implies a price increase of 45% is expected in the next year compared to the current price of 25.5. Check the ASSEMBLY BIOSCIENCES INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is ASSEMBLY BIOSCIENCES INC worth?

ASSEMBLY BIOSCIENCES INC (ASMB) has a market capitalization of 338.13M USD. This makes ASMB a Small Cap stock.


How many employees does ASSEMBLY BIOSCIENCES INC have?

ASSEMBLY BIOSCIENCES INC (ASMB) currently has 73 employees.


What are the support and resistance levels for ASSEMBLY BIOSCIENCES INC (ASMB) stock?

ASSEMBLY BIOSCIENCES INC (ASMB) has a support level at 25.49. Check the full technical report for a detailed analysis of ASMB support and resistance levels.


Is ASSEMBLY BIOSCIENCES INC (ASMB) expected to grow?

The Revenue of ASSEMBLY BIOSCIENCES INC (ASMB) is expected to grow by 17.15% in the next year. Check the estimates tab for more information on the ASMB EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy ASSEMBLY BIOSCIENCES INC (ASMB) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does ASSEMBLY BIOSCIENCES INC (ASMB) stock pay dividends?

ASMB does not pay a dividend.


When does ASSEMBLY BIOSCIENCES INC (ASMB) report earnings?

ASSEMBLY BIOSCIENCES INC (ASMB) will report earnings on 2025-11-05.


What is the Price/Earnings (PE) ratio of ASSEMBLY BIOSCIENCES INC (ASMB)?

ASSEMBLY BIOSCIENCES INC (ASMB) does not have a PE ratio as the earnings reported over the last twelve months were negative (-5.58).


What is the Short Interest ratio of ASSEMBLY BIOSCIENCES INC (ASMB) stock?

The outstanding short interest for ASSEMBLY BIOSCIENCES INC (ASMB) is 0.64% of its float. Check the ownership tab for more information on the ASMB short interest.


ASMB Technical Analysis

ChartMill assigns a technical rating of 9 / 10 to ASMB. When comparing the yearly performance of all stocks, ASMB is one of the better performing stocks in the market, outperforming 94.47% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

ASMB Fundamental Analysis

ChartMill assigns a fundamental rating of 2 / 10 to ASMB. While ASMB seems to be doing ok healthwise, there are quite some concerns on its profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

ASMB Financial Highlights

Over the last trailing twelve months ASMB reported a non-GAAP Earnings per Share(EPS) of -5.58. The EPS increased by 38.21% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -48.23%
ROE -215.27%
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%32.83%
Sales Q2Q%12.81%
EPS 1Y (TTM)38.21%
Revenue 1Y (TTM)54.77%

ASMB Forecast & Estimates

9 analysts have analysed ASMB and the average price target is 36.98 USD. This implies a price increase of 45% is expected in the next year compared to the current price of 25.5.

For the next year, analysts expect an EPS growth of 25.98% and a revenue growth 17.15% for ASMB


Analysts
Analysts82.22
Price Target36.98 (45.02%)
EPS Next Y25.98%
Revenue Next Year17.15%

ASMB Ownership

Ownership
Inst Owners13.01%
Ins Owners10.27%
Short Float %0.64%
Short Ratio0.48